Supply Chain Reset Puts India in Global Manufacturing Spotlight: ASSOCHAM

New Delhi, July 7: India is emerging as a key global manufacturing destination as companies worldwide look to diversify their supply chains, according to a report by the Associated Chambers of Commerce and Industry of India (ASSOCHAM).

The report highlights that India’s expanding industrial ecosystem, skilled workforce, improving infrastructure, policy reforms, and growing domestic market are strengthening its position in the global manufacturing landscape.

With businesses increasingly adopting a “China plus one” strategy to reduce supply chain risks, India is witnessing greater interest from global manufacturers across sectors such as electronics, automobiles, pharmaceuticals, renewable energy, and advanced technologies.

ASSOCHAM noted that continued investments in infrastructure, ease of doing business reforms, innovation, and skill development will be crucial to further enhancing India’s manufacturing competitiveness.

The report emphasised that India’s integration into global value chains can create new opportunities for investment, employment generation, and sustainable industrial growth.

India’s growing manufacturing capabilities are expected to play a significant role in shaping the country’s economic expansion and strengthening its position in the global supply network.

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Post

  • Government, corporates and global foundations join hands on PRAGATI to empower 20,000 agri-entrepreneurs

    Union Agriculture and Farmers Welfare Minister Shivraj Singh Chouhan recently launched PRAGATI, a nationwide initiative to build 20,000 agri-entrepreneurs and…

    Read More

  • Genespire and SR-TIGET Show Durable Preclinical Efficacy of Liver-Directed Gene Therapy for Methylmalonic Acidemia

    Milan, Italy, July 08 — Genespire, in collaboration with researchers at the San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), has today announced the publication of preclinical data supporting the potential of its liver-directed immune-shielded lentiviral gene therapy approach to treat methylmalonic acidemia (MMA), a severe inherited metabolic disorder. The findings, published in the Journal of Hepatology, show that a single systemic administration of a lentiviral vector encoding the MMUT gene led to sustained improvements in disease features in a validated mouse model of MMA, with effects lasting for the average lifespan of laboratory mice. Since the mice were treated when young, the study supports the durability of the gene therapy through postnatal growth and maturation of the liver. MMA is caused by a deficiency of methylmalonyl-CoA mutase, an enzyme that plays a critical role in the body’s metabolism of food. Its absence results in the accumulation of toxic metabolites that lead to recurrent metabolic crises, growth failure, neurological impairment, and multi-organ damage. In the study, researchers also treated mice with a dose containing an optimized MMUT transgene, thereby improving therapeutic efficacy. In the same mouse model of MMA, this…

    Read More

  • High-Energy Punjabi Party Anthem ‘Naachi Jaave’ Is Here

    Mumbai , July 8: The wait for this season’s ultimate party track is finally over. Tips Music has released its brand-new Punjabi single ‘Naachi Jaave‘,…

    Read More